Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,365,102
  • Shares Outstanding, K 36,403
  • Annual Sales, $ 181,280 K
  • Annual Income, $ -12,950 K
  • 60-Month Beta 1.69
  • Price/Sales 12.82
  • Price/Cash Flow N/A
  • Price/Book 12.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.17
  • Number of Estimates 5
  • High Estimate -0.10
  • Low Estimate -0.24
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +10.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.61 +14.40%
on 10/03/19
75.18 -13.87%
on 09/19/19
-8.48 (-11.58%)
since 09/18/19
3-Month
56.61 +14.40%
on 10/03/19
84.65 -23.50%
on 08/01/19
-11.48 (-15.06%)
since 07/18/19
52-Week
50.60 +27.98%
on 01/03/19
84.65 -23.50%
on 08/01/19
+2.44 (+3.92%)
since 10/18/18

Most Recent Stories

More News
Glaukos Corp Has Returned 0.5% Since SmarTrend Recommendation (GKOS)

SmarTrend identified a Downtrend for Glaukos Corp (NYSE:GKOS) on September 27th, 2019 at $63.72. In approximately 3 weeks, Glaukos Corp has returned 0.50% as of today's recent price of $63.40.

GKOS : 64.76 (-0.32%)
Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. IDE Trial for iStent infinite(TM)

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 64.76 (-0.32%)
Glaukos Products to be Subject of Multiple Presentations at American Academy of Ophthalmology Annual Meeting

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced...

GKOS : 64.76 (-0.32%)
Glaukos' iStent inject(R) Delivers Greater IOP Reduction vs. iStent(R) According to Newly Published Case Series

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced...

GKOS : 64.76 (-0.32%)
Shares of Zimmer Biomet Ho Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (ZBH , GKOS , ABT , DHR , BDX )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

ABT : 82.79 (+0.50%)
GKOS : 64.76 (-0.32%)
ZBH : 137.61 (-0.65%)
Uptrend Call Working As Glaukos Corp Stock Rises 12.3% (GKOS)

SmarTrend identified an Uptrend for Glaukos Corp (NYSE:GKOS) on September 5th, 2019 at $64.73. In approximately 3 weeks, Glaukos Corp has returned 12.28% as of today's recent price of $72.68.

GKOS : 64.76 (-0.32%)
SEMG, PVTL, FCSC and AVDR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

Rigrodsky & Long, P.A. announces that it is investigating:

SEMG : 16.29 (+1.69%)
PVTL : 14.93 (+0.07%)
VMW : 152.14 (+0.04%)
GKOS : 64.76 (-0.32%)
Shares of Dexcom Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (DXCM , GKOS , PODD , DHR , BSX )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

DXCM : 156.92 (+0.16%)
GKOS : 64.76 (-0.32%)
PODD : 153.74 (-1.75%)
Lifshitz & Miller LLP Announces Investigation of Avedro, Inc., Cambrex Corporation, Cardinal Health, Inc., Farfetch Limited Investors, Gannett Co., Inc., Pluralsight, Inc., Textron, Inc. and Vitamin Shoppe, Inc.

Avedro, Inc. (AVDR)

CBM : 59.51 (+0.03%)
CAH : 51.54 (+0.64%)
GCI : 10.91 (-0.18%)
GKOS : 64.76 (-0.32%)
PS : 16.79 (-2.50%)
TXT : 46.01 (-3.64%)
VSI : 6.51 (-0.15%)
Multiple Presentations to Showcase Glaukos Products at 2019 European Society of Cataract and Refractive Surgeons Congress

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced...

GKOS : 64.76 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

See More Share

Trade GKOS with:

Business Summary

Glaukos Corporation is an ophthalmic medical technology company. The Company develops, manufactures and markets medical devices for the treatment of glaucoma. Its product pipeline consists of iStent Inject, the iStent Supra and iDose. The company operates primarily in United States, Germany, Europe,...

See More

Key Turning Points

2nd Resistance Point 66.63
1st Resistance Point 65.70
Last Price 64.76
1st Support Level 63.82
2nd Support Level 62.87

See More

52-Week High 84.65
Fibonacci 61.8% 71.64
Fibonacci 50% 67.63
Last Price 64.76
Fibonacci 38.2% 63.61
52-Week Low 50.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar